Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2022-08-02 06:44:01]
5 Years H
4
Impact Factor
0.33
5 Years IF
0.17
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.15 0 0 0 0 0 0 0 0 0 0 0.07
1991 0 0.13 0 0 0 0 0 0 0 0 0 0 0.07
1992 0 0.12 0 0 0 0 0 0 0 0 0 0 0.08
1993 0 0.17 0 0 0 0 0 0 0 0 0 0 0.13
1994 0 0.16 0 0 0 0 0 0 0 0 0 0 0.07
1995 0 0.22 0 0 0 0 0 0 0 0 0 0 0.11
1996 0 0.23 0 0 0 0 0 0 0 0 0 0 0.13
1997 0 0.26 0 0 0 0 0 0 0 0 0 0 0.14
1998 0 0.28 0 0 0 0 0 0 0 0 0 0 0.17
1999 0 0.37 0 0 0 0 0 0 0 0 0 0 0.24
2000 0 0.51 0 0 0 0 0 0 0 0 0 0 0.23
2001 0 0.46 0 0 0 0 0 0 0 0 0 0 0.26
2002 0 0.5 0 0 0 0 0 0 0 0 0 0 0.28
2003 0 0.5 0 0 0 0 0 0 0 0 0 0 0.29
2004 0 0.55 0 0 0 0 0 0 0 0 0 0 0.33
2005 0 0.57 0 0 1 1 0 0 0 0 0 0 0.35
2006 0 0.56 0 0 1 2 0 0 1 1 0 0 0.33
2007 0 0.48 0 0 0 2 0 0 2 2 0 0 0.27
2008 0 0.56 0 0 1 3 3 0 1 2 0 0 0.29
2009 0 0.54 0 0 2 5 0 0 1 3 0 0 0.3
2010 0.33 0.49 0.11 0.2 4 9 0 1 1 3 1 5 1 0 0 0.28
2011 0 0.58 0 0 3 12 5 1 6 8 0 0 0.34
2012 0 0.63 0 0 3 15 6 1 7 10 0 0 0.33
2013 0.17 0.62 0.07 0.08 0 15 0 1 2 6 1 13 1 0 0 0.32
2014 0 0.63 0.11 0.08 3 18 8 2 4 3 12 1 0 1 0.33 0.32
2015 1 0.61 0.3 0.46 5 23 6 7 11 3 3 13 6 1 14.3 1 0.2 0.33
2016 0 0.62 0.04 0.07 4 27 1 1 12 8 14 1 0 0 0.33
2017 0.22 0.6 0.24 0.2 7 34 5 8 20 9 2 15 3 2 25 1 0.14 0.32
2018 0.18 0.6 0.21 0.37 9 43 10 9 29 11 2 19 7 1 11.1 2 0.22 0.34
2019 0.25 0.61 0.2 0.18 3 46 0 8 38 16 4 28 5 2 25 0 0.36
2020 0.25 0.7 0.16 0.14 12 58 8 9 47 12 3 28 4 0 1 0.08 0.67
2021 0.33 1.04 0.11 0.17 12 70 0 8 55 15 5 35 6 1 12.5 0 0.44
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12012The Many Faces of Innovation. (2012). Sussex, J ; Mordoh, A ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000154.

Full description at Econpapers || Download paper

7
22018The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009.

Full description at Econpapers || Download paper

6
32011The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Devlin, Nancy ; Garrison, L ; Hawe, E. In: Consulting Reports. RePEc:ohe:conrep:000192.

Full description at Econpapers || Download paper

6
42014The Trajectory of Dementia in the UK - Making a Difference. (2014). O'Neill, Phill ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cockcroft, L ; Sussex, J ; Lewis, F. In: Consulting Reports. RePEc:ohe:conrep:000518.

Full description at Econpapers || Download paper

4
52014The Expanding Value Footprint of Oncology Treatments. (2014). Towse, Adrian ; Shah, Koonal ; Garrison, L ; Mestre-Ferrandiz, J ; Hernandez-Villafuerte, K ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:000050.

Full description at Econpapers || Download paper

4
62008Medical Research: Whats It Worth?. (2008). Europe, Rand ; Of, Office . In: Consulting Reports. RePEc:ohe:conrep:000236.

Full description at Econpapers || Download paper

4
72017Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?. (2017). Towse, Adrian ; Hampson, Grace ; Marsden, G. In: Consulting Reports. RePEc:ohe:conrep:001802.

Full description at Econpapers || Download paper

3
82015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Devlin, Nancy ; Cole, Amanda ; Barnsley, P ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576.

Full description at Econpapers || Download paper

3
92020Indication-Based Pricing (IBP) Consultation Report. (2020). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002261.

Full description at Econpapers || Download paper

2
102015Data Governance Arrangements for Real-World Evidence. (2015). Towse, Adrian ; Cole, Amanda ; Mestre-Ferrandiz, J ; Garrison, L. In: Consulting Reports. RePEc:ohe:conrep:001660.

Full description at Econpapers || Download paper

2
112020Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?. (2020). Lorgelly, Paula ; Shah, K ; Hernandez-Villafuerte, K ; Herdman, M. In: Consulting Reports. RePEc:ohe:conrep:002249.

Full description at Econpapers || Download paper

2
122020Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?. (2020). Zhang, Kyann ; Garau, Martina ; Cubi-Molla, Patricia ; Errea, M. In: Consulting Reports. RePEc:ohe:conrep:002247.

Full description at Econpapers || Download paper

2
132018Barriers to Uptake of Minimal Access Surgery in the United Kingdom. (2018). Sampson, Christopher ; Lorgelly, Paula ; Cole, Amanda ; O'Neill, P. In: Consulting Reports. RePEc:ohe:conrep:001976.

Full description at Econpapers || Download paper

2
142016Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. (2016). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Devlin, Nancy ; Cubi-Molla, Patricia. In: Consulting Reports. RePEc:ohe:conrep:001699.

Full description at Econpapers || Download paper

2
15Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market. (2017). Lorgelly, Paula ; Hampson, Grace ; Berdud, Mikel ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001933.

Full description at Econpapers || Download paper

1
162018A Critique of the Paper The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List. (2018). Shaw, B ; Hernandez-Villafuerte, K ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002015.

Full description at Econpapers || Download paper

1
172017Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries. (2017). Zamora, Bernarda ; Garau, Martina ; Mestre-Ferrandiz, J ; O'Neill, P ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001818.

Full description at Econpapers || Download paper

1
182015Estimation of Future Cases of Dementia from Those Born in 2015. (2015). Lewis, F. In: Consulting Reports. RePEc:ohe:conrep:001645.

Full description at Econpapers || Download paper

1
192020A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold. (2020). , Towse ; FERRARO, . In: Consulting Reports. RePEc:ohe:conrep:002284.

Full description at Econpapers || Download paper

1
202015Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK. (2015). Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cole, Amanda ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001595.

Full description at Econpapers || Download paper

1
212018Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. (2018). Towse, Adrian ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:001978.

Full description at Econpapers || Download paper

1
222020Realising the Broader Value of Vaccines in the UK. (2020). Brassel, Simon ; Steuten, L ; O'Neill, P ; Neri, M. In: Consulting Reports. RePEc:ohe:conrep:002282.

Full description at Econpapers || Download paper

1
232010Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe. (2010). Towse, Adrian ; Puig-Peiro, R ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000212.

Full description at Econpapers || Download paper

1
242017Policy Options for Formulary Development in Middle-income Countries. (2017). Towse, Adrian ; Garau, Martina ; Grewal, S ; Garrison, L ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001784.

Full description at Econpapers || Download paper

1
252019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108.

Full description at Econpapers || Download paper

1
262020International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making. (2020). Zhang, Kyann ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:002271.

Full description at Econpapers || Download paper

1
27Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation. (2018). Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002096.

Full description at Econpapers || Download paper

1
282014Obstructive Sleep Apnoea: Health Economics Report. (2014). Garau, Martina ; Sussex, J ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:001504.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12008Medical Research: Whats It Worth?. (2008). Europe, Rand ; Of, Office . In: Consulting Reports. RePEc:ohe:conrep:000236.

Full description at Econpapers || Download paper

3
22018The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009.

Full description at Econpapers || Download paper

3
32020Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?. (2020). Zhang, Kyann ; Garau, Martina ; Cubi-Molla, Patricia ; Errea, M. In: Consulting Reports. RePEc:ohe:conrep:002247.

Full description at Econpapers || Download paper

2
42020Indication-Based Pricing (IBP) Consultation Report. (2020). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002261.

Full description at Econpapers || Download paper

2
52018Barriers to Uptake of Minimal Access Surgery in the United Kingdom. (2018). Sampson, Christopher ; Lorgelly, Paula ; Cole, Amanda ; O'Neill, P. In: Consulting Reports. RePEc:ohe:conrep:001976.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 5
YearTitle
2021The economic theory of cost?effectiveness thresholds in health: Domestic and international implications. (2021). Hollis, Aidan ; Moradpour, Javad. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:5:p:1139-1151.

Full description at Econpapers || Download paper

2021Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?. (2021). Cubi-Molla, Patricia ; Devlin, Nancy ; Buxton, Martin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:5:d:10.1007_s40258-021-00648-2.

Full description at Econpapers || Download paper

2021A reply to “Who would benefit from average value?based pricing?”. (2021). Pertile, Paolo ; Levaggi, Rosella. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:9:p:2284-2286.

Full description at Econpapers || Download paper

2021Payment Models for Multi-Indication Therapies. (2021). Neri, Margherita ; Cookson, G ; Cole, A. In: Consulting Reports. RePEc:ohe:conrep:002380.

Full description at Econpapers || Download paper

2021Modifying NICE’s Approach to Equity Weighting. (2021). McCabe, Christopher ; Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00988-2.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2020

YearCiting document
2020Economic evaluation of meningococcal vaccines: considerations for the future. (2020). Shah, Koonal ; Lorgelly, Paula ; York, Laura ; Landa, Paolo ; Wright, Claire ; Bloom, David E ; Glennie, Linda ; Postma, Maarten J ; Smith, Vinny ; Levy, Pierre ; HERNaNDEZ-VILLAFUERTE, KARLA ; Al-Janabi, Hareth ; Christensen, Hannah ; Towse, Adrian K ; Diez-Domingo, Javier ; Salisbury, David M ; Farkouh, Raymond ; Damm, Oliver . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:2:d:10.1007_s10198-019-01129-z.

Full description at Econpapers || Download

Recent citations received in 2018

YearCiting document
2018Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals. (2018). Lorgelly, Paula ; Cole, Amanda ; Sullivan, R ; Towse, A. In: Research Papers. RePEc:ohe:respap:002030.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4.

Full description at Econpapers || Download paper